Valvular heart disease (VHD) is a growing public health concern globally, with increasing disease burden and rising interest in advanced treatment strategies such as transcatheter interventions. However, there remains a significant lack of real-world data regarding echocardiography practices, disease prevalence and progression, referral patterns, and treatment pathways. Addressing these gaps is critical for improving patient care and informing clinical decision-making. South Korea provides a unique opportunity to conduct a nationwide retrospective echocardiographic study due to its advanced healthcare infrastructure, high patient volume, and strong tradition in clinical research. The current study aims to evaluate the real-world burden and clinical journey of patients with moderate or severe valvular disease over a 10-year period, based on echocardiographic and electronic medical record (EMR) data collected from multiple tertiary centers across the country.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Prevalence of Moderate and Severe Valvular Heart Disease (VHD)
Timeframe: January 1, 2010 - December 31, 2020
Etiological Classification of Aortic Stenosis (AS)
Timeframe: January 1, 2010 - December 31, 2020
Etiological Classification of Aortic Regurgitation (AR)
Timeframe: January 1, 2010 - December 31, 2020
Etiological Classification of Mitral Regurgitation (MR)
Timeframe: January 1, 2010 - December 31, 2020
Classification of Tricuspid Regurgitation (TR)
Timeframe: January 1, 2010 - December 31, 2020
Disease Progression and Treatment Pathway
Timeframe: January 1, 2010 - December 31, 2020